Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;206(3):307-13.
doi: 10.1016/j.amjsurg.2012.10.038. Epub 2013 May 7.

Management of external ear melanoma: the same or something different?

Affiliations

Management of external ear melanoma: the same or something different?

Teresa S Jones et al. Am J Surg. 2013 Sep.

Abstract

Background: The external ear represents a site with high ultraviolet exposure and thin skin overlying cartilage. The aim of this study was to determine if ear melanomas have different characteristics than cutaneous melanomas in other anatomic sites.

Methods: The evaluation of patients treated at a tertiary care center.

Results: Sixty patients were treated for ear melanoma (87% male, mean age = 56.7, mean thickness = 1.65 mm). Seven of thirty-two patients (22%) who underwent sentinel lymph node biopsy had positive nodes. Twenty (33%) patients had recurrence including 6 patients with negative sentinel lymph nodes (SLNs) and 5 patients with positive SLNs. Three of 10 patients (30%) treated with Mohs surgery had local recurrence.

Conclusions: The overall local and systemic recurrences are similar to those previously reported. There is a higher recurrence rate than expected in patients with a negative SLN and a high local recurrence rate after Mohs surgery. Our data suggest that SLN evaluation may be less accurate in ear melanomas and that Mohs surgery may be associated with a relatively high local recurrence rate.

Keywords: Ear; Melanoma; Recurrence; Sentinel lymph node.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Patient treatment and recurrence patterns.
Figure 2
Figure 2
(A) Overall survival. (B) Survival for patients with and without recurrence. (C) Survival for patients with +/− SLN biopsies.

References

    1. [Accessed May 15, 2011];American Cancer Society Facts and Figures. 2005 Available at: www.cancer.org.
    1. Jemal A, Siegel R, Xu J, et al. Cancer statistics 2010. CA Cancer J Clin. 2010;60:277–300. - PubMed
    1. Larson DL, Larson JD. Head and neck melanoma. Clin Plast Surg. 2010;37:73–7. - PubMed
    1. Pino Rivero V, González Palomino A, Pantoja Hernández CG, et al. Malignant melanoma of the pinna. Importance of its diagnosis, treatment and prognostic factors. An Otorrinolaringol Ibero Am. 2006;33:545–50. - PubMed
    1. Jahn V, Breuninger H, Garbe C, et al. Melanoma of the ear: prognostic factors and surgical strategies. Br J Dermatol. 2006;154:310–8. - PubMed